Publication

Body weight course in the DIAbetes and LifEstyle Cohort Twente (DIALECT-1)-A 20-year observational study

Gant, C. M., Mensink, I., Binnenmars, S. H., van der Palen, J. A. M., Bakker, S. J. L., Navis, G. & Laverman, G. D., 19-Jun-2019, In : PLoS ONE. 14, 6, 14 p., 0218400.

Research output: Contribution to journalArticleAcademicpeer-review

Background

Although weight gain increases risk of type 2 diabetes, real-life data on the weight course in patients with established type 2 diabetes are scarce. We assessed weight course in a real-life diabetes secondary care setting and analyzed its association with patient characteristics, lifestyle habits and initiation of insulin, glucagon like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose co-transporter-2 inhibitors (SGLT-2i).

Methods

Data on weight, insulin, GLP-1 RA and SGLT-2i use were collected retrospectively (12 years) and prospectively (8 years) from patients included in the DIAbetes and LifEstyle Cohort Twente-1 (DIALECT-1, n = 450, age 63 +/- 9 years, 58% men, diabetes duration [7-18] years). Lifestyle habits were assessed using validated questionnaires. The association of clinical parameters with body mass index (BMI) course was determined using linear mixed models. Patients who underwent bariatric surgery (n = 19) had a distinct BMI course and were excluded from the study.

Results

Baseline BMI was 31.3 (0.3) and was higher in women, patients aged

Conclusions

High BMI that real-life patients with type 2 diabetes gained earlier in life, remained stable in the following decades. Weight loss interventions should remain a priority, and GLP-1 RA might be considered to support weight loss.

Original languageEnglish
Article number0218400
Number of pages14
JournalPLoS ONE
Volume14
Issue number6
Publication statusPublished - 19-Jun-2019

    Keywords

  • FAT MASS, TYPE-2, INTERVENTIONS, GAIN, AGE, QUESTIONNAIRE, ASSOCIATIONS, METAANALYSIS, VALIDITY, OUTCOMES

View graph of relations

Download statistics

No data available

ID: 98552336